Open access · OA
via OpenAlex
Oxidative stress in Alzheimer disease
Cell Adhesion & Migration · 2009 · ▲ 459 citations
Abstract
Alzheimer disease (AD) is a progressive dementia affecting a large proportion of the aging population. The histopathological changes in AD include neuronal cell death, formation of amyloid plaques and neurofibrillary tangles. There is also evidence that brain tissue in patients with AD is exposed to oxidative stress (e.g., protein oxidation, lipid oxidation, DNA oxidation and glycoxidation) during the course of the disease. Advanced glycation endproducts (AGEs) are present in amyloid plaques in AD, and its extracellular accumulation may be caused by an accelerated oxidation of glycated proteins. AGEs participate in neuronal death causing direct (chemical) and indirect (cellular) free radical production and consequently increase oxidative stress. The development of drugs for the treatment of AD that breaks the vicious cycles of oxidative stress and neurodegeneration offer new opportunities. These approaches include AGE-inhibitors, antioxidants and anti-inflammatory substances, which prevent free radical production.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4161/cam.3.1.7402
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Gella, A., & Durany, N. (2009). Oxidative stress in Alzheimer disease. <em>Cell Adhesion & Migration</em>. https://doi.org/10.4161/cam.3.1.7402
Vancouver
Gella A, Durany N. Oxidative stress in Alzheimer disease. Cell Adhesion & Migration. 2009. doi:10.4161/cam.3.1.7402.
BibTeX
@article{alejandro2009Oxidat,
title = {Oxidative stress in Alzheimer disease},
author = {Alejandro Gella and Núria Durany},
journal = {Cell Adhesion & Migration},
year = {2009},
doi = {10.4161/cam.3.1.7402},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Free Radical Biology and Medicine 2012
Preprint · OA
Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease
Neurology 1998
Citation only
Alzheimer's disease
Oxidative Medicine and Cellular Longevity 2012
Open access · CC-BY
Antioxidant Therapies for Alzheimer's Disease
Texas ScholarWorks (Texas Digital Library) 2014
Preprint · OA
Inhibiting amyloid precursor protein to prevent neurodegeneration in Down syndrome and Alzheimer's disease
Antioxidants 2025
Open access · CC-BY
Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective
Neurochemistry International 2026
Citation only